Adverse events26

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 26

Type	Event	Organ system	Group	Affected	At risk
other	back pain	Musculoskeletal and connective tissue disorders	Standard Dose Teriparatide	0	39
other	back pain	Musculoskeletal and connective tissue disorders	High Dose Teriparatide	2	37
serious	wrist fracture	Musculoskeletal and connective tissue disorders	Standard Dose Teriparatide	2	39
serious	wrist fracture	Musculoskeletal and connective tissue disorders	High Dose Teriparatide	1	37
serious	anal cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Standard Dose Teriparatide	0	39
serious	anal cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	High Dose Teriparatide	1	37
serious	breast cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Standard Dose Teriparatide	2	39
serious	breast cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	High Dose Teriparatide	0	37
serious	clavicle fracture	Musculoskeletal and connective tissue disorders	Standard Dose Teriparatide	1	39
serious	clavicle fracture	Musculoskeletal and connective tissue disorders	High Dose Teriparatide	0	37
serious	fibula avulsion fracture	Musculoskeletal and connective tissue disorders	Standard Dose Teriparatide	1	39
serious	fibula avulsion fracture	Musculoskeletal and connective tissue disorders	High Dose Teriparatide	0	37
serious	humeral fracture	Musculoskeletal and connective tissue disorders	Standard Dose Teriparatide	1	39
serious	humeral fracture	Musculoskeletal and connective tissue disorders	High Dose Teriparatide	0	37
serious	kidney cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Standard Dose Teriparatide	1	39
serious	kidney cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	High Dose Teriparatide	0	37
serious	pancreatitis	Endocrine disorders	Standard Dose Teriparatide	1	39
serious	pancreatitis	Endocrine disorders	High Dose Teriparatide	0	37
serious	rib fracture	Musculoskeletal and connective tissue disorders	Standard Dose Teriparatide	1	39
serious	rib fracture	Musculoskeletal and connective tissue disorders	High Dose Teriparatide	0	37

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02176382/events

API reference For AI assistants

Adverse events26

Sources 3

Read this list from software.